Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives

C Hart, N van Es, M Voigtlaender - Hämostaseologie, 2024 - thieme-connect.com
Over the past two decades, the incidence of cancer-associated thrombosis (CAT) has
increased. It is nowadays a common and often serious complication among patients with …

Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding

A Alqahtani, D Alhousari, A Ali… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Asparaginase is essential to chemotherapy regimens for acute lymphoblastic
leukemia (ALL). Survival of patients with ALL has improved since incorporating …

Real-world presentation and prognostic effect of allogeneic blood transfusion during the intensive induction phase in Pediatric Acute Lymphoblastic Leukemia

K Qiu, X Liao, Y Li, K Huang, H Xu, J Fang, D Zhou - Cancers, 2023 - mdpi.com
Simple Summary In China, approximately 15,000 cases of childhood acute lymphoblastic
leukemia (ALL) are diagnosed each year, and it is also the most common hematological …

[HTML][HTML] Analysis of RAS gene mutations in adverse events during first induction chemotherapy in childhood acute lymphoblastic leukemia

T Chen, N Wei, W Lv, L Qu, H Liu - Translational Pediatrics, 2023 - ncbi.nlm.nih.gov
Background The rat sarcoma virus (RAS) pathway controls cell proliferation, differentiation,
and apoptosis, which have been implicated in the pathogenesis of various hematological …

Retrospective review of the toxicities and change in dosing patterns for pegaspargase in patients with acute lymphoblastic leukemia/lymphoma and T-cell lymphoma

G Baek, M Kim, M Lee, S O'Connor… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Pegaspargase (PEG) is a key component of standard regimens for acute
lymphoblastic leukemia/lymphoma (ALL) and extranodal natural killer/T-cell lymphoma …

Acute pancreatitis in children with acute lymphoblastic leukemia

A Maziarczyk, M Lambach, P Kura… - Acta Haematologica …, 2023 - journals.viamedica.pl
One of the most common causes of acute pancreatitis in children are medications. These
include L-asparaginase, glucocorticoids and 6-mercaptopurine, which are widely used in …

Нативные и пегилированные препараты L-аспарагиназы: оценка эффективности и токсичности при лечении острого лимфобластного лейкоза по протоколу …

МА Шервашидзе, ДС Смирнова… - …, 2024 - oncohematology.abvpress.ru
Аннотация Введение. Препараты L-аспарагиназы–неотъемлемый компонент
полихимиотерапии в лечении пациентов с острым лимфобластным лейкозом (ОЛЛ) …

Factors clínics i biològics associats a toxicitat en el tractament de la leucèmia limfoblàstica aguda pediàtrica

M Mesegué Medà - 2023 - diposit.ub.edu
[cat] La leucèmia limfoblàstica aguda (LLA) és l'expansió clonal de cèl· lules malignes
originades a partir de progenitors hematopoètics i és el càncer pediàtric més freqüent. La …

Genetic factors in acute pancreatitis

DC Whitcomb - Acute Pancreatitis: A Practical Guide for Clinicians, 2024 - Springer
Acute pancreatitis (AP) describes the inflammatory response of the pancreas after it is
stressed or injured above a threshold level. In animal models of AP, the type and amount of …